Confidential Treatment Requested by Fortive Corporation

SKADDEN, ARPS, SLATE, MEAGHER & FLOM LLP FOUR TIMES SQUARE NEW YORK, NY 10036   ------   TEL: (212) 735-7886 FAX: (212) 735-2000 www.skadden.com   FOIA CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. § 200.83 BY FORTIVE CORPORATION   March 9, 2016   FIRM/AFFILIATE
OFFICES ----     BOSTON CHICAGO HOUSTON LOS ANGELES NEW YORK PALO ALTO WASHINGTON WILMINGTON ---- BEIJING BRUSSELS FRANKFURT HONG KONG LONDON MOSCOW MUNICH PARIS SÃO PAULO SHANGHAI SINGAPORE SEOUL

VIA EDGAR

Amanda Ravitz

Assistant Director

Securities and Exchange Commission

Division of Corporation Finance

100 F. Street N.E.

Washington, D.C. 20549

RE: Fortive Corporation

Registration Statement on Form 10

Filed December 3, 2015 (File No. 001-37654)

Dear Ms. Ravitz:

On behalf of Fortive Corporation (the “Company”), set forth below is a supplement to the Company’s response to comment 5 contained in the letter from the staff (the “Staff”) of the Securities and Exchange Commission (the “Commission”), dated December 30, 2015 (the “Comment Letter”), and the Company’s response, dated January 13, 2016 (the “Response Letter”), relating to the Company’s registration statement on Form 10 filed with the Commission on December 3, 2015 (the “Registration Statement”). Comment 5 in the Comment Letter related to the Company’s 2013 results of operations and requested that the Company provide a list of countries in the Middle East in which the Company had received orders.

******************************REDACTED******************************

Confidential Treatment Requested by Fortive Corporation

Amanda Ravitz

March 9, 2016

Page 2

Please direct any questions concerning this letter to the undersigned at (212) 735-7886.

Sincerely,

/s/ Thomas W. Greenberg            

Thomas W. Greenberg

cc: James A. Lico

James F. O’Reilly